Professor Sir Andrew Pollard, director of the Oxford Vaccine Group, stated the Beta variant first recognized in South Africa can escape vaccine immunity however he expects the AstraZeneca jab will nonetheless give “very excessive safety” in opposition to hospital admission and demise.
“The Beta variant can be within the UK, and simply as with the Delta variant it is capable of escape vaccine immunity to some extent,” he informed BBC Radio 4’s At this time programme.
“It is truly fairly good at escaping vaccine immunity and so we’d anticipate it to have the ability to unfold in vaccinated populations.
“We all know that individuals who have had RNA vaccines, just like the Pfizer vaccine, in addition to the Oxford/AstraZeneca vaccine, can develop into contaminated with the Beta variant.”
Requested concerning the effectiveness of the AstraZeneca vaccine in opposition to the Beta variant, he stated: “There’s one actually necessary research, which was carried out in South Africa by Johnson and Johnson, and that confirmed with a single dose of that vaccine there was 100% safety in opposition to hospitalisation and demise.
“The RNA vaccine, the Pfizer vaccine, and the Oxford/AstraZeneca vaccine, are given as two doses. The AstraZeneca vaccine is similar to the Johnson and Johnson one and we might anticipate from the biology right here to have very excessive safety in opposition to hospitalisation and demise, and I am completely assured that that would be the case, as a result of that is how vaccines work.”